Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent.
Daphne van VlietEline H PloumenTineke H PinxterhuisRosaly A BuitenAdel AminianCarl E SchotborghPeter W DanseAriel RoguinRutger L AnthonioEdouard BenitPaolo ZoccaCarine J M DoggenClemens von BirgelenPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
The final 5-year analysis of the randomized BIONYX trial showed favorable and similar long-term outcomes of safety and efficacy for Onyx ZES and Orsiro SES in both all-comers and patients with diabetes.